Search clinical trials for: cadaveric organ donor

Total 62221 results

Genzyme, a Sanofi Company

Completed

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

Cadaveric Donor Renal Transplantation | Acute Renal Allograft Rejection | Induction Therapy

United States, France, Spain, United Kingdom, Germany
Nazarbayev University

Completed

Functional Reserve Estimation of Donor Kidney

End-stage Renal Disease

Kazakhstan
Instituto Mexicano del Seguro Social

Completed

Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney

Renal Insufficiency

Mexico
National University Hospital, Singapore
Changi General Hospital; National Heart Centre Singapore; Singapore Clinical...

Unknown

Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study (NICHE)

Cardio-Renal Syndrome

Singapore
University of Liege

Unknown

Effects of Preconditioning With Sevoflurane During Organ Procurement From Brain Dead Donors: Impact on Early Function of Liver Allografts

Post-transplantation Liver Allograft Function

Belgium
University of Medicine and Dentistry of New Jersey

Completed

Ischemic Preconditioning of Liver in Cadaver Donors

Liver Cirrhosis | Liver Disease

United States
University of Medicine and Dentistry of New Jersey

Completed

Remote Ischemic Preconditioning In Abdominal Organ Transplantation (RIPCOT)

Liver Disease | Pancreas Disease | Kidney Disease

United States
Mahidol University

Unknown

Efficacy and Safety of Everolimus in de Novo Kidney Transplant Recipients of ECD or AKI Donors

Transplantation of Kidney | ECD | Expanded Criteria Donor
Vanderbilt University
National Cancer Institute (NCI)

Terminated

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Chronic Myeloproliferative Disorders | Cancer Survivor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
University of California, San Francisco
California Transplant Donor Network

Completed

The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup

Renal Function | Mild Hypothermia | Deceased Organ Donor

United States
University of Cincinnati
Roche Pharma AG

Completed

Pilot Study for HLA Identical Living Donor Renal Transplant Recipients

Renal Transplant

United States
Institut Universitari Dexeus
FUNDACION DEXEUS SALUT DE LA DONA; Ayudas Merck Serono de Investigación 2012

Completed

Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation

Ovulation Induction | INFERTILITY | Fertility Preservation | Oocyte Donation | Vitrification

Spain
University of Miami

Completed

Desensitization Protocol for Deceased Donor List

Transplant; Failure, Kidney

United States
East Carolina University
Novartis Pharmaceuticals

Completed

Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)

Transplant; Failure, Kidney

United States
Ain Shams University

Completed

Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation

Health Related Quality of Life

Egypt
University of Minnesota

Completed

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

Cancer
Medical University of Vienna

Completed

Impact of Preterm Single Donor Milk in Very Low Birth Weight Infants

Infant, Premature, Diseases

Austria
St. Barnabas Medical Center
Health Resources and Services Administration (HRSA); University of Medicine...

Completed

Enhancing Education Regarding Living Donor Transplant Among Kidney Transplant Candidates

Chronic Kidney Disease | End-stage Renal Disease | Kidney Transplant | Living-Donor Kidney Transplant

United States
Samsung Medical Center

Unknown

Tolerance Induction in Living Donor Kidney Transplantation With Hematopoietic Stem Cell Transplantation

End Stage Renal Disease

Korea, Republic of
Universitaire Ziekenhuizen KU Leuven

Unknown

Study on the Effect of Surgical Intestinal Manipulation (IMMO)

Intestinal Manipulation

Belgium
National Institute of Allergy and Infectious Diseases...
Comprehensive International Program of Research on AIDS

Completed

Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, China

HIV Infections

China
Mayo Clinic
National Cancer Institute (NCI)

Withdrawn

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

Lymphoma

United States
Yonsei University

Completed

Comparison of the Protective Effect of Desflurane and Propofol in Patients With Renal Transplantation

Healthy | End Stage Renal Disease

Korea, Republic of
University of California, San Francisco
National Cancer Institute (NCI)

Unknown

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Lymphoma | Kidney Cancer | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Terminated

Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer

United States
University of Edinburgh

Unknown

Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation

Lymphoproliferative Disorder

United Kingdom
Milton S. Hershey Medical Center
National Cancer Institute (NCI)

Unknown

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Cancer

United States
Huazhong University of Science and Technology
B. Braun Medical SA

Completed

Effect of Remote Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney Transplantation

Kidney Diseases | Urologic Diseases | Renal Insufficiency, Chronic | Renal Insufficiency | Kidney Failure, Chronic | Kidney Failure

China
Ain Shams University

Completed

Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the Limits

Recurrence of HCC After LDLT

Egypt
University of Rochester

Completed

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Kidney Cancer

United States
National Institute of Allergy and Infectious Diseases...
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival

Liver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation

United States
Aragon Institute of Health Sciences
Fondo de Investigacion Sanitaria

Unknown

Impact of Melatonin in the Pretreatment of Organ Donor and the Influence in the Evolution of Liver Transplant.

Evidence of Liver Transplantation

Spain
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Cancer

United States
Virginia Center for Reproductive Medicine

Completed

The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors

Ovarian Hyperstimulation Syndrome

United States
Asan Medical Center

Completed

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Cancer

Korea, Republic of
Ain Shams University

Completed

Causes of Disqualification of Egyptian Potential Living Liver Donors

Donors Safety

Egypt
Azienda Ospedaliera di Padova

Completed

Use of N-Acetylcysteine During Liver Procurement

Liver Diseases | Liver Failure | Liver Failure, Acute | Carcinoma, Hepatocellular | Liver Neoplasms

Italy
Stanford University
Novacea

Terminated

A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer

Prostatic Neoplasms | Prostate Cancer

United States
Organogenesis

Terminated

Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds

Wounds

Canada
University of California, San Francisco
National Cancer Institute (NCI)

Completed

Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission

Leukemia | Thrombocytopenia | Fanconi Anemia | Congenital Amegakaryocytic Thrombocytopenia | Severe Congenital Neutropenia | Diamond-blackfan Anemia

United States
University of California, San Francisco

Completed

Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

Follicular Lymphoma | Renal Cell Carcinoma | Acute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Aplastic Anemia | Myelodysplasia | NHL | Myeloproliferative Diseases

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host Disease | Myelodysplastic/Myeloproliferative Neoplasms

United States
University of Zurich

Unknown

The Perioperative Value of Platelet Counts in Predicting Outcome After Liver Transplantation

Death | Complication

Switzerland
University of Miami
Immune Tolerance Network (ITN)

Completed

Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients

Kidney Transplantation | Kidney Failure | Kidney Disease

United States
Northside Hospital, Inc.
Blood and Marrow Transplant Group of Georgia

Completed

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Lymphoma | Kidney Cancer | Myelodysplastic Syndromes | Leukemia | Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases

United States
Roswell Park Cancer Institute

Withdrawn

Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant

Primary Myelofibrosis | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditions
Mount Sinai Hospital, Canada

Unknown

Safety Study of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury

Hypoxia | Respiratory Failure | Acute Respiratory Distress Syndrome | Acute Lung Injury | Sodium Nitroprusside

Canada
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Kidney Cancer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia

Fanconi Anemia

United States, Brazil
Seoul National University Hospital
Roche Pharma AG

Unknown

Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney Transplant

End Stage Renal Disease

Korea, Republic of

Search clinical trials for: cadaveric organ donor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations